Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 4 Insider Changes in Ownership
  2. 144 Insider Sale of Securities
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 8-K Event Regulation FD disclosure
  10. 4 Insider Changes in Ownership
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13D/A Stake Beneficial Ownership Report
  14. 4 Insider Changes in Ownership
  15. 8-K Event Material agreement · Unregistered share sale · Other events
  16. 8-K Event Regulation FD disclosure · Other events
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 36 · 701 filings